BETAPRO - 2.5 MG

Tablet

Pack Size : 10 Tablet x 1 Strip

Generics : Betamethasone valerate 0.01% Topical

Manufacturer : Beximco Pharmaceuticals Ltd.

Best Price * TK 60.00

* Delivery will be done in Dhaka city only.

Alternative Product

Ointment Bet-A 15 gm Acme Laboratories Ltd.

Tk 33.10

Ointment Beta A 0.0001 Acme Laboratories Ltd.

Tk 35.11

More Information About - BETAPRO - 2.5 MG

Description

Generic Name

Bisoprolol

Precaution

Impaired Renal or Hepatic Function. Lactation: excretion in milk unknown; use caution

Indication

Hypertension, Angina pectoris, Congestive heart failure

Contra Indication

Patients with cardiogenic shock, overt cardiac failure, second or third degree AV block and marked sinus bradycardia.

Dose

N/A

Side Effect

1-10% Dizziness (10%),Dyssomnia (8%-10%),Bradyarrhythmia (9%),Upper respiratory infection (5%),Diarrhea (4%),Rhinitis (4%),Arthralgia (3%),Cough (3%),Dyspnea (2%),Nausea (2%),Pharyngitis (2%),Sinusitis (2%),Vomiting (2%) <1% Cold extremities,Hypotension,Depression,Dyspepsia,Bronchospasm Frequency Not Defined Aggravate CHF,Decrease HDL,Hypertriglyceridemia,Mask symptoms of hypoglycemia,Decreased exercise tolerance,Raynaud's phenomenon,May increase triglyceride levels and insulin resistance

Pregnancy Category

Name : C

Description

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Mode of Action

Bisoprolol selectively and competitively blocks beta1-receptors but has little or no effect on beta2-receptors except at high doses.

Interaction

May potentiate AV conduction time and may increase negative inotropic effect w/ class I antiarrhythmic drugs (e.g. quinidine, disopyramide, propafenone). Concomitant catecholamine-depleting drugs (e.g. reserpine, guanethidine) may produce excessive sympathetic activity. May exacerbate rebound HTN upon discontinuance of clonidine treatment. Increased risk of bradycardia w/ digitalis glycosides. Reduced hypotensive effect w/ NSAIDs.

Pregnancy Category Note

Pregnancy Category: C Lactation: excretion in milk unknown; use caution

Adult Dose

The usual starting dose is 5 mg once daily. In some patients, 2.5 mg may be an appropriate starting dose. If the antihypertensive effect of 5 mg is inadequate, the dose may be increased to 10 mg and then, if necessary, to 20 mg once daily. For heart failure: Initially 1.25 mg once daily (in the morning) for 1 week then, if well tolerated, increased to 2.5 mg once daily for 1 week, then 3.75 mg once daily for 1 week, then 5 mg once daily for 4 weeks, then 7.5 mg once daily for 4 weeks, then 10 mg once daily; max. 10 mg daily. Hepatic impairment: Severe: Initially, 2.5 mg/day. Max: 10 mg/day. Elderly: Hypertension 2.5-20 mg PO qDay Heart Failure 1.25 mg PO qDay; not to exceed 10 mg/day

Child Dose

N/A

Renal Dose

Renal impairment: CrCl (ml/min) <40 Initial: 2.5 mg/day.

Administration

May be taken with or without food.

Disclaimer

The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.